Astrotech Subsidiary and Cleveland Clinic Partner to Develop a Rapid COVID-19 Breath Test
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Astrotech (ASTC) Surges on Development Deal with Cleveland Clinic for Rapid COVID-19 Breath Test
October 20, 2020 5:17 PM EDTAstrotech (NASDAQ: ASTC) is gaining 77% after-hours Tuesday after the company signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotechs BreathTest-1000 mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a... More
